Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Joel A. Hennenfent"'
Publikováno v:
American Journal of Health-System Pharmacy. 73:1395-1405
Purpose The privileging of pharmacists for clinical activities and the impact that privileging has on enhancing the scope of pharmacy practice in health systems are reviewed. Summary Health-system pharmacists or pharmacy leaders must gain a thorough
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6e165ebe2a21a3281b9802acfc3a59a
https://doi.org/10.2146/ajhp150820
https://doi.org/10.2146/ajhp150820
Autor:
Glen T. Schumock, Larry J. Koesterer, Annette M. Karageanes, Joel A. Hennenfent, Funda Tiryaki, Edith A. Nutescu, Bruce L. Lambert
Publikováno v:
American Journal of Health-System Pharmacy. 68:1239-1244
Purpose The use of anticoagulant therapy for the prevention and treatment of venous thromboembolism (VTE) and acute coronary syndrome (ACS) among hospital inpatients was evaluated. Methods Medication-use data were retrospectively collected on 1716 pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0771a5829f70c30cb840b14fb76a7f31
https://doi.org/10.2146/ajhp100543
https://doi.org/10.2146/ajhp100543
Autor:
Yoojung Yang, Keith A. Rodvold, Glen T. Schumock, Frank P. Tverdek, Gordon D. Schiff, Martin V. McBride, Bruce L. Lambert, Joel A. Hennenfent, Anne Marie Trese
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 67(12)
Purpose The use of policies and practices regarding surveillance, decolonization, and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections and the formulary status of various antimicrobial agents used to treat MRSA were characte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfaedd07cd672c9abb8083e15da73e4c
https://pubmed.ncbi.nlm.nih.gov/20516473
https://pubmed.ncbi.nlm.nih.gov/20516473
Autor:
Thomas P. Lonergan, Joel A. Hennenfent, Way Y. Huey, Thomas C. Bailey, S. Troy McMullin, Michael E. Tonn, David J. Ritchie, Robyn Schaiff
Publikováno v:
Archives of Internal Medicine. 159
Hospital pharmacists make many recommendations that improve patients' quality of care and/or reduce drug costs. While the impact of quality-of-care interventions is difficult to quantify, those limited to cost savings could be assessed in a prospecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63bb75d20f30df8709928d1ecf25a0a9
https://doi.org/10.1001/archinte.159.19.2306
https://doi.org/10.1001/archinte.159.19.2306
Autor:
John S. Clark, Lea S. Eiland, Stephen C. Adams, Kristine K. Gullickson, Kevin C. Pendleton, Carrie A. Sincak, Erin R. Fox, Janet M. Kozakiewicz, Todd A. Karpinski, Tim Brown, Leigh Ann Ross, Kevin W. Garey, Paul S. Driver, Steve Rough, Rick Couldry, Scott Knoer, Traci L. Metting, John D. Pastor, Melinda M. Neuhauser, Douglas Slain, Mark L. Britton, Edward H. Eiland, Timothy J. Stroup, Julie A. Murphy, Robert L. Poole, Phil Ayers, Eric T. Hola, Joel A. Hennenfent, Angela T. Cassano, Kate Farthing
Publikováno v:
American Journal of Health-System Pharmacy. 69:1166-1166
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93b898f8c27b430870d498bfc401cffd
https://doi.org/10.2146/sp120002
https://doi.org/10.2146/sp120002